Virpax Pharmaceuticals Navigates Stock, Governance, and Compliance Challenges
PremiumCompany AnnouncementsVirpax Pharmaceuticals Navigates Stock, Governance, and Compliance Challenges
3M ago
Virpax Pharmaceuticals files to sell common stock and warrants, no amount given
Premium
The Fly
Virpax Pharmaceuticals files to sell common stock and warrants, no amount given
3M ago
Virpax Pharmaceuticals regains compliance with Nasdaqminimum bid price
Premium
The Fly
Virpax Pharmaceuticals regains compliance with Nasdaqminimum bid price
4M ago
Virpax announces $2.5M loan financing, additional pact with investor
PremiumThe FlyVirpax announces $2.5M loan financing, additional pact with investor
4M ago
Virpax Pharmaceuticals downgraded to Hold at Maxim on capital constraints
Premium
The Fly
Virpax Pharmaceuticals downgraded to Hold at Maxim on capital constraints
6M ago
Virpax Pharmaceuticals downgraded to Hold from Buy at Maxim
Premium
The Fly
Virpax Pharmaceuticals downgraded to Hold from Buy at Maxim
6M ago
Virpax Pharmaceuticals files to sell common stock and warrants, no amount given
PremiumThe FlyVirpax Pharmaceuticals files to sell common stock and warrants, no amount given
7M ago
Virpax Pharmaceuticals’ Settlement Strain: Risk of Stalled Development and Hindered Growth
Premium
Company Announcements
Virpax Pharmaceuticals’ Settlement Strain: Risk of Stalled Development and Hindered Growth
8M ago
Scilex enters release, settlement agreement with Virpax Pharmaceuticals
Premium
The Fly
Scilex enters release, settlement agreement with Virpax Pharmaceuticals
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100